Advanced search
Publication Cover
HIV Clinical Trials Volume 10, 2009 - Issue 2
Submit an article Journal homepage
31
Views
2
CrossRef citations to date
0
Altmetric
Brief reports

Hot Topics in HIV and Hepatitis Coinfection: Noninvasive Diagnosis of Liver Disease, Liver Transplantation, and New Drugs for Treatment of Hepatitis Coinfection

Jürgen Kurt RockstrohDepartment of Medicine University of Bonn, Bonn, GermanyCorrespondence[email protected]
Pages 110-115 | Published online: 06 Jan 2015

REFERENCES

  • Bedossa P, Dagere D, Parades V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38: 1449–1457.
  • Regev A, Berho M, Jeffers LJ, et al. Sampling error and intra-observer variation in liver biopsy in patients with chronic HCV-infection. Am J Gastroenterol. 2002;97:2614–2618.
  • Piccinio F, Sagnelli E, Pasquale G, et al. Complications fol-lowing percutaneous liver biopsy: a multicenter retrospec-tive study on 68,276 biopsies. J Hepatol. 1986;2:165–173
  • Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nation-wide survey for the group of epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32:477–481.
  • Sterling RK, Lissen, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibro-sis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317–1321.
  • Trang T, Petersen JR, Snyder N. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index. Clin Chim Acta. 2008;397:51–54.
  • Myer S, Benhamou Y, Imbert-Bismut F, et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus coinfected patients. AIDS. 2003;17:721–725.
  • de Lédinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr. 2006;41(2):175–179.
  • Panos G, Holmes P, Mandalia S, et al. Determination of transient elastography (TE) cut-off values for the detec-tion of significant hepatitis fibrosis through systemic review and meta-analysis and evaluation in HIV-positive individuals or the effect of body mass index (BMI), alcohol intake, smoking, gender, age on liver stiffness measure-ments. In: Program and abstracts from the 17th Interna-tional AIDS Conference; August 3–8, 2008; Mexico City. THAB 0203.
  • Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus related decompensated cirrhosis. Hepatology. 2005;41:779–789.
  • Rockstroh JK, Spengler U. HIV and hepatitis C virus coin-fection. Lancet Infect Dis. 2004;4:437–444.
  • Miro JM, Laguno M, Moreno A, Rimola A, Hospital Clinic OLT in HIV Working Group. Management of end-stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)? J Hepatol. 2006;44:S140–145.
  • Mindikoglu AL, Regev A, Magder LS. Impact of human immunodeficiency virus on survival after liver transplanta-tion: analysis of United Network for Organ Sharing database. Transplantation. 2008;85:359–368.
  • Vogel M, Voigt E, Schafer N, et al. Orthotopic liver trans-plantation in human immunodeficiency virus (HIV) positive patients: outcome of 7 patients from the Bonn cohort. Liver Transplant. 2005;11:1515–1521.
  • Wojcik K, Vogel M, Voigt E, et al. Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort. AIDS. 2007;21:1363–1365.
  • Vogel M, Voigt E, Michaelis HC, et al. Management of drug-to-drug interactions between cyclosporine A and the protease inhibitor lopinavir/ritonavir in liver-transplanted HIV infected patients. Liver Transplant. 2004;10:939–944.
  • Jain AK, Venkataramanan R, Shapiro R, et al. The inter-action between antiretroviral agents and tracolimus in liver and kidney transplantation. Liver Transplant. 2002;8:841–845.
  • Bruno R, Sacchi P, Puoti M, et al. Natural history of compen-sated viral cirrhosis in a cohort of patients with HIV-infection. J Acquir Immune Syndr. 2007;46:297–303.
  • Marcellin P, Heathcote EJ, Buti M, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. New Engl J Med. 2008;359:2442–2455.
  • Rockstroh JK, Bahgani S, Benhamou Y, et al., EACS Exec-utive Committee. European AIDS Clinical Society (EACS) for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV infected adults. HIV Med. 2008;9:82–88.
  • Manns MP, Foster GR, Rockstroh JK, et al. The way forward in HCV treatment - finding the right path. Nature Rev Drug Discov. 2007;6:991–1000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.